Notice

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

Updates regarding government operating status and resumption of normal operations can be found at USA.gov.

News Releases

Showing results filtered by:

December 2015

November 2015

  • NIH Statement on World AIDS Day 2015

    November 30, 2015

    ​When the first cases of what would become known as AIDS were reported in 1981, scientists and physicians did not know the cause and had no therapies to treat those who were infected. Times have changed and today physicians can offer their patients highly effective medicines that work as both treatment and prevention. 

  • NIH Publishes Criteria for Research on Organ Transplantation Between People with HIV Infection

    November 25, 2015

    The U.S. Department of Health and Human Services published safeguards and criteria for research to assess the safety and effectiveness of solid organ transplantation from donors with HIV infection to recipients with HIV infection. 

  • NIH-Sponsored Clinical Trial of Chikungunya Vaccine Opens

    November 24, 2015

    An experimental vaccine to protect against the mosquito-borne illness chikungunya is being tested in a Phase 2 trial sponsored by the National Institutes of Health.

  • NIH Launches Initiative to Develop Long-Acting HIV Treatment and Prevention Tools

    November 18, 2015

    The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, launched a major initiative to advance novel approaches to treat and prevent HIV infections based on broadly neutralizing antibodies (bNAbs)

  • RSV Pediatric Vaccine Candidate Shows Promise in Early Clinical Trial

    November 5, 2015

    Scientists from the National Institute of Allergy and Infectious Diseases and colleagues  have developed a vaccine candidate to protect infants and young children against respiratory syncytial virus that appears to elicit a stronger protective immune response than the previous lead vaccine candidate.

October 2015

September 2015

August 2015

  • NIH Launches Human RSV Study

    August 26, 2015

    ​A new study will expose healthy adult volunteers to respiratory syncytial virus (RSV). Better understanding of how adults develop RSV infection and immune system responses to infection will help researchersdevelop and test future antivirals and vaccines to combat the virus. 

  • NIH Scientists and Colleagues Successfully Test MERS Vaccine in Monkeys and Camels

    August 19, 2015

    ​National Institutes of Health scientists and colleagues report that an experimental vaccine given six weeks before exposure to Middle East respiratory syndrome coronavirus (MERS-CoV) fully protects rhesus macaques from disease.

  • NIH-Developed Epstein-Barr Virus Vaccine Elicits Potent Neutralizing Antibodies in Animals

    August 13, 2015

    National Institute of Allergy and Infectious Diseases researchers and their collaborators have developed an experimental, nanoparticle-based vaccine against Epstein-Barr virus that can induce potent neutralizing antibodies in vaccinated mice and nonhuman primates.

  • NIH-Funded Study Establishes Genomic Data Set on Lassa Virus

    August 13, 2015

    An international team of researchers has developed the largest genomic data set in the world on Lassa virus. The new genomic catalog contains viral genomes collected from patient samples in Sierra Leone and Nigeria, as well as field samples from the major animal reservoir of Lassa virus-the rodent Mastomys natalensis. 

  • Single Dose Ebola Vaccine is Safe and Effective in Monkeys against Outbreak Strain

    August 6, 2015

    National Institutes of Health scientists report that a single dose of an experimental Ebola virus (EBOV) vaccine completely protects cynomolgus macaques against the current EBOV outbreak strain when given at least 7 days before exposure, and partially protects them if given 3 days prior.

July 2015

June 2015

May 2015

  • Starting Antiretroviral Treatment Early Improves Outcomes for HIV-Infected Individuals

    May 27, 2015

    ​Scientists from the National Institute of Allergy and Infectious Diseases and colleagues have identified 80 currently licensed drugs that demonstrated antiviral activity against Zaire ebolavirus in laboratory testing. 

  • HIV Reservoirs Remain Obstacles to Cure

    May 19, 2015

    Antiretroviral therapy (ART) has proven lifesaving for people infected with HIV; however, the medications are a lifelong necessity for most HIV-infected individuals and present practical, logistical, economic and health-related challenges. 

  • HIV Vaccine Awareness Day 2015

    May 18, 2015

    ​Vaccination has historically been the best method for protecting against and ultimately defeating mankind's most devastating infectious diseases. Although the path to developing a safe and effective HIV vaccine has so far been difficult, achieving this goal remains key to realizing a durable end to the global HIV/AIDS pandemic. 

  • NYVAC-HIV Vaccine Used in the HVTN 092 and HVTN 096 Clinical Trials

    May 13, 2015

    ​The National Institute of Allergy and Infectious Diseases  has learned that NYVAC-HIV, an investigational HIV vaccine previously administered in two small HIV vaccine studies, was contaminated with a bacterium called Mycoplasma hyorhinis.

  • NIAID Recognizes Significant Milestone in Ebola Vaccine Study

    May 7, 2015

    In partnership with the Liberian Ministry of Health, the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health is pleased to announce the successful enrollment of all 1,500 planned participants in the Phase 2 portion of the Ebola vaccine clinical trial known as PREVAIL (Partnership for Research on Ebola Vaccines in Liberia).

  • Mobile Phone Microscope Rapidly Detects Parasite Levels in Blood

    May 6, 2015

    Scientists from the National Institute of Allergy and Infectious Diseases and the University of California, Berkeley, and colleagues have developed a mobile phone microscope to measure blood levels of the parasitic filarial worm Loa loa. 

  • NIH Statement on World Asthma Day 2015

    May 5, 2015

    On World Asthma Day 2015, the National Institutes of Health stands with the international community to renew our commitment to advance our understanding of asthma and develop effective strategies to manage and prevent the disease.

April 2015

  • World Malaria Day

    April 25, 2015

    On World Malaria Day 2015, the National Institutes of Health reaffirms its longstanding commitment to reducing the global burden of this devastating and persistent disease. 

  • NIH-Funded Research Leads to Approval of Drug for Acute Radiation Injury

    April 21, 2015

    ​The Food and Drug Administration has approved the use of filgrastim (trade name Neupogen) to increase survival of people acutely exposed to high doses of radiation that damage the bone marrow, for example, as a result of a nuclear power plant accident or terrorist attack. 

  • NIH Launches Largest Clinical Trial Focused on HIV-Related Cardiovascular Disease

    April 15, 2015

    Researchers have begun enrolling participants in a multicenter international clinical trial to test whether statin administration can reduce the risk for major adverse cardiovascular events, such as heart attacks, strokes, and heart disease, in people with HIV infection. 

  • NIH, South African Medical Research Council Award $8 Million in HIV, TB Grants

    April 13, 2015

    ​The National Institutes of Health and the South African Medical Research Council are awarding 31 grants to U.S. and South African scientists to support research targeting HIV/AIDS, tuberculosis and HIV-related co-morbidities and cancers.

  • NIH Funds Nine Antimicrobial Resistance Diagnostics Projects

    April 9, 2015

    ​The National Institute of Allergy and Infectious Diseases has awarded more than $11 million in first-year funding for nine research projects supporting enhanced diagnostics to rapidly detect antimicrobial-resistant bacteria. 

  • Anti-HIV Antibody Shows Promise in First Human Study

    April 8, 2015

    A single infusion of an experimental anti-HIV antibody called 3BNC117 resulted in significantly decreased HIV levels that persisted for as long as 28 days in HIV-infected individuals, according to Phase 1 clinical trial findings published online in Nature. 

  • NIH-Funded Scientists Identify Receptor for Asthma-Associated Virus

    April 6, 2015

    ​Scientists funded by the National Institute of Allergy and Infectious Diseases have identified a cellular receptor for rhinovirus C, a cold-causing virus that is strongly associated with severe asthma attacks. 

  • Experimental Ebola Vaccine Safe, Prompts Immune Response

    April 1, 2015

    ​An early-stage clinical trial of an experimental Ebola vaccine conducted at the National Institutes of Health and the Walter Reed Army Institute of Research found that the vaccine, called VSV-ZEBOV, was safe and elicited robust antibody responses in all 40 of the healthy adults who received it.

March 2015

  • Ebola Test Vaccines Appear Safe in Phase 2 Liberian Clinical Trial

    March 26, 2015

    Two experimental Ebola vaccines appear to be safe based on evaluation in more than 600 people in Liberia who participated in the first stage of the Partnership for Research on Ebola Vaccines in Liberia (PREVAIL) Phase 2/3 clinical trial. 

  • NIH Study Finds No Evidence of Accelerated Ebola Virus Evolution in West Africa

    March 26, 2015

    The Ebola virus in the ongoing West African outbreak appears to be stable-that is, it does not appear to be mutating more rapidly than viruses in previous Ebola outbreaks, and that is reassuring," said Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases.

  • NIH Statement on World TB Day 2015

    March 24, 2015

    World TB Day, March 24, marks the day in 1882 when German microbiologist Robert Koch announced his discovery of the bacterium that causes tuberculosis (TB). Despite the considerable progress made since that discovery, TB remains one of the world's deadliest diseases.

  • NIH Researchers Identify Red Blood Cell Traits Associated with Malaria Risk in Children

    March 24, 2015

    Researchers at the National Institute of Allergy and Infectious Diseases have determined that certain red blood cell traits in children can increase or decrease their risk for malaria. The findings could help identify future targets for new malaria drugs and vaccines. 

  • NIH-Funded Researchers Find Off-Patent Antibiotics Effectively Combat MRSA Skin Infections

    March 19, 2015

    Researchers funded by the National Institute of Allergy and Infectious Diseases have found that two common antibiotic treatments work equally well against bacterial skin infections caused by methicillin-resistant Staphylococcus aureus acquired outside of hospital settings.

  • NIH Researchers Develop Database on Healthy Immune System

    March 12, 2015

    ​An extensive database identifying immune traits, such as how immune cell function is regulated at the genetic level in healthy people, is reported by researchers from the National Institutes of Health (NIH) and their collaborators. 

  • NIH-Led Study to Assess Community-Based Hepatitis C Treatment in Washington, D.C.

    March 6, 2015

    National Institutes of Health  launched a clinical trial in Washington, DC, to examine whether primary care physicians and other health care providers can use a new antiviral therapy as effectively as specialist physicians to treat people with hepatitis C virus infection. 

February 2015

January 2015